Table 1.
Participant characteristics at baseline
| Variables | Standard | Intervention | p |
|---|---|---|---|
| Age,a median (IQR), year | 56 (36–64) | 46 (37–65) | 0.90 |
| Sex (male),b No (%) | 40 (51.9) | 38 (50) | 0.81 |
| Respiratory rate (the number of breaths per minute),a median (IQR) | 18 (17–19) | 18 (17–19) | 0.60 |
| Blood pressure (mmHg),c mean + SD | 124.56 (27.92) | 126.76 (17.61) | 0.56 |
| Pulse rate (beats per minute),a median (IQR) | 85 (80–89) | 90 (83–109) | 0.004 |
| Body temperature (°C),a median (IQR) | 37 (37–37.15) | 37.05 (37–38) | 0.10 |
| Cough,b No (%) | 49 (64.5) | 59 (77.6) | 0.07 |
| Myalgia,b No (%) | 44 (57.9) | 15 (19.7) | 0.001 |
| Dyspnea,b No (%) | 66 (85.7) | 62 (81.6) | 0.49 |
| Diarrhea,b No (%) | 4 (5.3) | 6 (7.9) | 0.51 |
| White blood cell (×103/µl),a median (IQR) | 5.7 (4.3–7.4) | 6.4 (5–9.8) | 0.04 |
| Hemoglobin (g/dl),a median (IQR) | 13.7 (12.5–14.7) | 13.5 (12.3–14.6) | 0.86 |
| Platelet (×103/µl),a median (IQR) | 172 (132–234) | 174 (142–219) | 0.80 |
| Plasma creatinine (mg/dl),a median (IQR) | 1.10 (0.90–1.30) | 1.10 (1–1.30) | 0.22 |
| Aspartate transaminase (U/L),a median (IQR) | 36.5 (21.25–50.75) | 28 (20–40.50) | 0.30 |
| Alanine transaminase (U/L),a median (IQR) | 22 (17.25–54.50) | 25 (18.5–40) | 0.83 |
| Alkaline phosphatase (IU/L),a median (IQR) | 188.5 (152.75–246) | 186 (130.50–206.50) | 0.58 |
| Total bilirubin (mg/dl),a median (IQR) | 0.86 (0.77–1.12) | 0.90 (0.70–1.15) | 0.73 |
| Direct bilirubin (mg/dl),a median (IQR) | 0.20 (0.115–0.325) | 0.20 (0.20–0.30) | 0.87 |
| Lactate dehydrogenase (U/L),a median (IQR) | 497 (384.5–603) | 491 (376.75–574.25) | 0.60 |
Note: The significant level is p < 0.05.
Abbreviation: IQR, interquartile range.
a
Mann–Whitney U‐test.
b
Chi‐squared tests.
c
Student's t‐test.